Christopher D. Saffore, PharmD, PhD

Director, International HEOR Strategy
AbbVie Inc.

Poster(s):

• (376) Real-world persistence of first-line advanced therapies in patients with psoriatic arthritis
  Wednesday, October 29, 2025